A study conducted by digestive healthcare company Oshi Health in partnership with a national health plan found that virtual multidisciplinary care for gastrointestinal disorders improves patient ...

John L. Marshall, MD: Zolbetuximab is a drug that you probably don’t know the name of, but you’re going to soon. Though you may have heard of claudin 18.2. Now, that’s been in the literature for a ...

We sought to evaluate the effects of an employer-sponsored digital digestive care program on health care spending. Study Design: Retrospective controlled cohort study. Methods: Using propensity score ...

Comparing outcomes for early and late drainage of malignant ascites. Background: Black individuals, including African Americans, experience a disproportionate cancer burden and exhibit the lowest ...

A new study suggests acidogenic foods may raise your gastrointestinal cancer risk. Acidogenic foods, like red and processed meats, create acid in your body. Eating more plants has been correlated with ...

A recent study has identified a potential new tool to help detect gastrointestinal cancers — the platelet-to-high-density lipoprotein ratio, or PHR. Researchers analyzed data from more than 19,000 ...

71.4% of MetaXplore™ reports from 4,616 patients identified actionable results 41.9% tested positive for abnormal microbiome markers linked to gastrointestinal health 9.9% tested positive for ...

Developing depression half a month after gastrointestinal (GI) disease presented an elevated risk of dementia among participants in a November study published in Alzheimer’s & Dementia. “These ...

Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic neuroendocrine ...